FRED HUTCHINSON CANCER CENTER
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia
- Conditions
- Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Fanconi AnemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Childhood Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With t(16;16)(p13;q22)Childhood Myelodysplastic Syndromes
- Interventions
- First Posted Date
- 2004-10-08
- Last Posted Date
- 2017-02-20
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 2
- Registration Number
- NCT00093743
- Locations
- 🇺🇸
Riley Hospital for Children, Indianapolis, Indiana, United States
🇺🇸Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
- Conditions
- First Posted Date
- 2004-09-02
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00002790
Monoclonal Antibody Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia in Remission or First Relapse
- Conditions
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2010-03-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00002554
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2004-08-23
- Last Posted Date
- 2010-04-02
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00002674
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
- Conditions
- Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)Adult Nasal Type Extranodal NK/T-cell Lymphoma
- Interventions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2020-01-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT00089011
- Locations
- 🇺🇸
VA Puget Sound Health Care System, Seattle, Washington, United States
🇺🇸LDS Hospital, Salt Lake City, Utah, United States
🇺🇸Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2011-07-15
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00089037
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
- Conditions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2011-11-30
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00089050
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
- Conditions
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00004158
- Locations
- 🇺🇸
University of Texas - MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸Sylvester Cancer Center, University of Miami, Miami, Florida, United States
🇺🇸Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma
- Conditions
- Hepatosplenic T-cell LymphomaIntraocular LymphomaNoncutaneous Extranodal LymphomaRecurrent Adult Diffuse Small Cleaved Cell LymphomaRecurrent Adult Grade III Lymphomatoid GranulomatosisTesticular LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Immunoblastic Large Cell LymphomaRecurrent Adult T-cell Leukemia/LymphomaRecurrent Cutaneous T-cell Non-Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2004-07-19
- Last Posted Date
- 2019-12-27
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 63
- Registration Number
- NCT00003196
- Locations
- 🇺🇸
City of Hope Medical Center, Duarte, California, United States
🇺🇸Stanford University Hospitals and Clinics, Stanford, California, United States
🇺🇸Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
- First Posted Date
- 2004-07-16
- Last Posted Date
- 2011-11-29
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00003874
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States